文献速递物质与行为成瘾

8161人饮酒的表观基因组关联研究及与酒精使用障碍病理生理学的关联:鉴定胱氨酸/谷氨酸转运体SLC7A11为顶级靶点

Epigenome-wide association study of alcohol consumption in N = 8161 individuals and relevance to alcohol use disorder pathophysiology: identification of the cystine/glutamate transporter SLC7A11 as a top target.
PubMed 文献 · Mol Psychiatry · 2021-12-02

本研究对8161人开展迄今最大单队列饮酒表观基因组关联研究(EWAS),发现2504个CpG位点与饮酒显著相关,前五位探针位于SLC7A11等基因。双样本孟德尔随机化证实饮酒对酒精使用障碍(AUD)风险的因果关系(IVW p=5.37×10-09),基于甲基化的预测因子可区分AUD病例,顶级探针cg06690548在AUD中呈强低甲基化并与重度饮酒天数及肝酶升高相关。

要点

  • 饮酒与2504个CpG位点显著相关,顶级探针位于SLC7A11(p=7.75×10-108)。
  • 孟德尔随机化证实饮酒对AUD风险有因果效应(IVW p=5.37×10-09)。
  • SLC7A11探针cg06690548在AUD中低甲基化,与重度饮酒天数及肝酶升高相关。

核心结论

  • EWAS发现样本及顶级探针在AUD中的验证提示,由SLC7A11甲基化变异介导的谷氨酸信号异常可能起重要作用。
  • 作者认为数据有趣,鉴于谷氨酸信号在脑和肝中的突出作用,可能为治疗干预提供重要靶点。

研究设计与样本

  • 迄今最大单队列饮酒表观基因组关联研究(EWAS),N=8161。
  • 在具有相关内表型的AUD人群及酒精相关动物模型中交叉验证发现。
  • 顶级探针在独立AUD与对照队列(N=615)中重复验证。
  • 采用双样本孟德尔随机化分析饮酒对AUD风险的因果关系。

主要发现

  • 2504个CpG位点与饮酒显著相关(Bonferroni p值<6.8×10-8)。
  • 前五位探针位于SLC7A11(p=7.75×10-108)、JDP2(p=1.44×10-56)、GAS5(p=2.71×10-47)、TRA2B(p=3.54×10-42)和SLC43A1(p=1.18×10-40)。
  • 双样本孟德尔随机化证实饮酒对AUD风险的因果关系(逆方差加权法 p=5.37×10-09)。
  • 基于甲基化的饮酒预测因子在两个独立队列中可区分AUD病例(p=6.32×10-38和p=5.41×10-14)。
  • 顶级EWAS探针cg06690548位于胱氨酸/谷氨酸转运体SLC7A11,在独立AUD与对照队列(N=615)中重复验证,在AUD中显示强低甲基化(p<10-17)。

关键数值与推荐

  • 该探针CpG甲基化降低与AUD个体重度饮酒天数增加(p<10-4)及肝功酶升高(GGT p=1.03×10-21、ALT p=1.29×10-6、AST p=1.97×10-8)一致相关。
  • 死后脑分析显示AUD个体额叶皮质SLC7A11表达增加,动物模型显示肝脏表达显著增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alcohol misuse is common in many societies worldwide and is associated with extensive morbidity and mortality, often leading to alcohol use disorders (AUD) and alcohol-related end-organ damage. The underlying mechanisms contributing to the development of AUD are largely unknown; however, growing evidence suggests that alcohol consumption is strongly associated with alterations in DNA methylation. Identification of alcohol-associated methylomic variation might provide novel insights into pathophysiology and novel treatment targets for AUD. Here we performed the largest single-cohort epigenome-wide association study (EWAS) of alcohol consumption to date (N = 8161) and cross-validated findings in AUD populations with relevant endophenotypes, as well as alcohol-related animal models. Results showed 2504 CpGs significantly associated with alcohol consumption (Bonferroni p value < 6.8 × 10-8) with the five leading probes located in SLC7A11 (p = 7.75 × 10-108), JDP2 (p = 1.44 × 10-56), GAS5 (p = 2.71 × 10-47), TRA2B (p = 3.54 × 10-42), and SLC43A1 (p = 1.18 × 10-40). Genes annotated to associated CpG sites are implicated in liver and brain function, the cellular response to alcohol and alcohol-associated diseases, including hypertension and Alzheimer's disease. Two-sample Mendelian randomization confirmed the causal relationship of consumption on AUD risk (inverse variance weighted (IVW) p = 5.37 × 10-09). A methylation-based predictor of alcohol consumption was able to discriminate AUD cases in two independent cohorts (p = 6.32 × 10-38 and p = 5.41 × 10-14). The top EWAS probe cg06690548, located in the cystine/glutamate transporter SLC7A11, was replicated in an independent cohort of AUD and control participants (N = 615) and showed strong hypomethylation in AUD (p < 10-17). Decreased CpG methylation at this probe was consistently associated with clinical measures including increased heavy drinking days (p < 10-4), increased liver function enzymes (GGT (p = 1.03 × 10-21), ALT (p = 1.29 × 10-6), and AST (p = 1.97 × 10-8)) in individuals with AUD. Postmortem brain analyses documented increased SLC7A11 expression in the frontal cortex of individuals with AUD and animal models showed marked increased expression in liver, suggesting a mechanism by which alcohol leads to hypomethylation-induced overexpression of SLC7A11. Taken together, our EWAS discovery sample and subsequent validation of the top probe in AUD suggest a strong role of abnormal glutamate signaling mediated by methylomic variation in SLC7A11. Our data are intriguing given the prominent role of glutamate signaling in brain and liver and might provide an important target for therapeutic intervention.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Lohoff FW, Clarke TK, Kaminsky ZA, et al. Epigenome-wide association study of alcohol consumption in N = 8161 individuals and relevance to alcohol use disorder pathophysiology: identification of the cystine/glutamate transporter SLC7A11 as a top target. Mol Psychiatry. 2021. PMID: 34857913. doi:10.1038/s41380-021-01378-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。